Product Manager, Sequencing Platforms
OXFORD, OXFORDSHIRE, United Kingdom
Hybrid
Role Overview
Oxford Nanopore Technologies is seeking a Product Manager to support the lifecycle management and commercial success of our sequencing platforms.
This role is focused on the on-market management of our sequencing platforms, ensuring they continue to deliver strong customer value, remain competitive, and evolve in line with user needs and organisational priorities. The Product Manager will work cross-functionally to translate customer, commercial, and technical insights into clear product requirements and actionable roadmaps, supporting ongoing product development and improvement.
Sitting at the interface of science, technology, and commercial teams, the role will act as a key voice of the customer, ensuring that development activities are grounded in real-world needs and that product decisions are supported by robust data and evidence.
The Role
What you will be responsible for
Reporting to the Associate Director of Product Management, you will be responsible for on-market product management
- Act as the voice of the customer (VoC), translating insights from customers and internal stakeholders into clear product requirements and priorities
- Develop and deliver data-driven product roadmaps, balancing customer needs, technical feasibility, and delivery timelines
- Coordinate with operations and supply chain to ensure product availably and lifecycle sustainability and proactively identify and mitigating delivery risks
- Work cross-functionally with R&D, Product Marketing and Commercial to ensure aligned and timely execution of product initiatives
- Act as a product champion, supporting commercial activities through development of sales collateral, defining supporting technical work, and assisting with complex technical queries
What We Are Looking For...
Essential
- Experience in product management of physical devices within biotechnology, life sciences, or medical devices.
- Demonstrated ability to use data to inform decisions and influence stakeholders
- Strong cross-functional collaboration skills, with experience working in matrixed environments
- Experience managing projects or product initiatives end-to-end, from requirements through delivery
- Excellent written and verbal communication skills
Desirable
- Experience working next generation sequencing systems or genomics applications.
- Experience working under product development and commercialisation (PD&C) or equivalent development frameworks
- Exposure to global markets and diverse customer segments
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-Hybrid
About UsOxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Skills Required
- Product management experience of physical devices within biotechnology, life sciences, or medical devices.
- Demonstrated ability to use data to inform decisions and influence stakeholders.
- Strong cross-functional collaboration skills; experience in matrixed environments.
- Experience managing projects or product initiatives end-to-end, from requirements through delivery.
- Excellent written and verbal communication skills.
- Experience working with next generation sequencing systems or genomics applications.
- Experience working under product development and commercialisation (PD&C) or equivalent frameworks.
- Exposure to global markets and diverse customer segments.
Oxford Nanopore Technologies Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Oxford Nanopore Technologies and has not been reviewed or approved by Oxford Nanopore Technologies.
-
Fair & Transparent Compensation — Pay is considered good to above average across many roles, with employer-provided ranges visible for several U.S. commercial and applications positions and company materials emphasizing market‑competitive base pay. Commercial and some senior technical posts, particularly in the U.S., are positioned as competitive and often paired with strong variable components.
-
Equity Value & Accessibility — All‑employee share plans in the UK and a U.S. employee stock purchase plan indicate broad access to equity as part of total reward. Company communications highlight attractive bonus and share plans that add meaningful upside beyond base pay.
-
Healthcare Strength — U.S. roles indicate strong health insurance and core protections, while official materials and country overviews reference private medical coverage and wellbeing support. These elements position the health package as a notable strength alongside cash compensation.
Oxford Nanopore Technologies Insights
What We Do
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
.png){kind=logo}
